EDAP TMS S.A. (FOCL) - Total Liabilities
Based on the latest financial reports, EDAP TMS S.A. (FOCL) has total liabilities worth $77.77 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EDAP TMS S.A. (FOCL) asset resilience to evaluate the company's liquid asset resilience ratio.
EDAP TMS S.A. - Total Liabilities Trend (2006–2025)
This chart illustrates how EDAP TMS S.A.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see EDAP TMS S.A. (FOCL) total assets.
EDAP TMS S.A. Competitors by Total Liabilities
The table below lists competitors of EDAP TMS S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mega Uranium Ltd.
TO:MGA
|
Canada | CA$34.20 Million |
|
Chant Sincere Co Ltd
TW:6205
|
Taiwan | NT$1.14 Billion |
|
St.Shine Optical Co Ltd
TWO:1565
|
Taiwan | NT$1.26 Billion |
|
BBMG Corporation
F:9BM
|
Germany | €174.70 Billion |
|
Brazil Potash Corp.
NYSE:GRO
|
USA | $15.37 Million |
|
Atp Ticari Bilgisayar Agi ve Elektrik Guc Kaynaklari Uretim Pazarlama ve Ticaret
IS:ATATP
|
Turkey | TL633.82 Million |
|
JIUMAOJIU INTL HLDGS LTD
F:3YU
|
Germany | €2.61 Billion |
|
Amrutanjan Health Care Limited
NSE:AMRUTANJAN
|
India | Rs902.90 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down EDAP TMS S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See EDAP TMS S.A. balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -24.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EDAP TMS S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EDAP TMS S.A. (2006–2025)
The table below shows the annual total liabilities of EDAP TMS S.A. from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $59.58 Million | +27.40% |
| 2024-12-31 | $46.77 Million | +22.28% |
| 2023-12-31 | $38.25 Million | +21.53% |
| 2022-12-31 | $31.47 Million | +1.86% |
| 2021-12-31 | $30.90 Million | -9.31% |
| 2020-12-31 | $34.07 Million | +23.20% |
| 2019-12-31 | $27.66 Million | +6.40% |
| 2018-12-31 | $25.99 Million | +4.57% |
| 2017-12-31 | $24.86 Million | +7.59% |
| 2016-12-31 | $23.10 Million | -11.07% |
| 2015-12-31 | $25.98 Million | +27.23% |
| 2014-12-31 | $20.42 Million | -15.76% |
| 2013-12-31 | $24.24 Million | -17.50% |
| 2012-12-31 | $29.38 Million | -3.80% |
| 2011-12-31 | $30.54 Million | -15.81% |
| 2010-12-31 | $36.27 Million | -9.06% |
| 2009-12-31 | $39.88 Million | +7.58% |
| 2008-12-31 | $37.08 Million | -16.87% |
| 2007-12-31 | $44.60 Million | +156.75% |
| 2006-12-31 | $17.37 Million | -- |
About EDAP TMS S.A.
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more